Brain penetration of the novel free radical trapping neuroprotectant NXY-059 in rats subjected to permanent focal ischemia.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Brain Research

• Publication date

  2006-02-09

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.BRAINRES.2005.12.035PMID 16448628
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Free radical trapping as a therapeutic approach to neuroprotection in stroke: experimental and clinical studies with NXY-059 and free radical scavengers.

  2005cited by this paper
• Permeability Studies on In Vitro Blood–Brain Barrier Models: Physiology, Pathology, and Pharmacology

  2005cited by this paper
• Tolerability of NXY-059 at Higher Target Concentrations in Patients With Acute Stroke

  2003cited by this paper
• Functional and histological evidence for the protective effect of NXY-059 in a primate model of stroke when given 4 hours after occlusion.

  2003cited by this paper
• In vitro blood-brain barrier permeability and cerebral endothelial cell uptake of the neuroprotective nitrone compound NXY-059 in normoxic, hypoxic and ischemic conditions.

  2002cited by this paper
• Effect of NXY‐059 on infarct volume after transient or permanent middle cerebral artery occlusion in the rat; studies on dose, plasma concentration and therapeutic time window

  2002cited by this paper
• NXY-059, a novel free radical trapping compound, reduces cortical infarction after permanent focal cerebral ischemia in the rat.

  2001cited by this paper
• Comparison of the radical trapping ability of PBN, S-PBN and NXY-059

  2001cited by this paper
• NXY-059, a Free Radical–Trapping Agent, Substantially Lessens the Functional Disability Resulting From Cerebral Ischemia in a Primate Species

  2001cited by this paper
• Dynamics of cerebral injury, perfusion, and blood-brain barrier changes after temporary and permanent middle cerebral artery occlusion in the rat.

  1999cited by this paper
• Neuroprotective Effects of a Novel Nitrone, NXY-059, after Transient Focal Cerebral Ischemia in the Rat

  1999cited by this paper
• Extracellular space structure revealed by diffusion analysis.

  1998cited by this paper
• Alterations in cerebral endothelial cell function in ischemia.

  1996cited by this paper
• Inflammatory reactions at the blood-endothelial interface in acute stroke.

  1996cited by this paper
• Role of Neutrophils in Radical Production during Ischemia and Reperfusion of the Rat Brain: Effect of Neutrophil Depletion on Extracellular Ascorbyl Radical Formation

  1995cited by this paper
• Temporal profile of ischemic tissue damage, neutrophil response, and vascular plugging following permanent and transient (2H) middle cerebral artery occlusion in the rat.

  1994cited by this paper
• Reversible middle cerebral artery occlusion without craniectomy in rats.

  1989cited by this paper
• Molecules mediating adhesion of T and B cells, monocytes and granulocytes to vascular endothelial cells.

  1988cited by this paper

• Stabilization of CXCL12 (SDF-1α) via silk fibroin films enhances stem cell migration/retention and functional recovery after stroke

  2025cites this paper
• The role of oxidative stress in blood-brain barrier disruption during ischemic stroke: Antioxidants in clinical trials.

  2024cites this paper
• Advances in nitric oxide regulators for the treatment of ischemic stroke.

  2023cites this paper
• Recent Advances on Nitrones Design for Stroke Treatment.

  2020cites this paper
• Tetramethylpyrazine nitrone improves motor dysfunction and pathological manifestations by activating the PGC-1α/Nrf2/HO-1 pathway in ALS mice.

  2020cites this paper
• New Quinolylnitrones for Stroke Therapy: Antioxidant and Neuroprotective ( Z)- N- tert-Butyl-1-(2-chloro-6-methoxyquinolin-3-yl)methanimine Oxide as a New Lead-Compound for Ischemic Stroke Treatment.

  2019cites this paper
• How is edaravone effective against acute ischemic stroke and amyotrophic lateral sclerosis?

  2017cites this paper
• Quinolinyl Nitrone RP19 Induces Neuroprotection after Transient Brain Ischemia.

  2017cites this paper
• Current preclinical studies on neuroinflammation and changes in blood-brain barrier integrity by MDMA and methamphetamine.

  2014cites this paper
• Selective gelatinase inhibitor neuroprotective agents cross the blood-brain barrier.

  2012cites this paper
• Therapeutic effects of tetramethylpyrazine nitrone in rat ischemic stroke models

  2012cites this paper
• A Clinically Relevant Rabbit Embolic Stroke Model for Acute Ischemic Stroke Therapy Development: Mechanisms and Targets

  2012cites this paper
• Emerging treatments for acute ischemic stroke include use of thrombolytic and neuroprotective agents

  2012cites this paper
• Anti-cancer activity of nitrones and observations on mechanism of action.

  2011cites this paper
• Protective effects of MLIF analogs on cerebral ischemia-reperfusion injury in rats.

  2011cites this paper
• Développement de nouveaux agents anti-radicalaires de type nitroxyde et nitrone utilisables comme sondes et agents thérapeutiques

  2011cites this paper
• Translational Stroke Research Using a Rabbit Embolic Stroke Model: A Correlative Analysis Hypothesis for Novel Therapy Development

  2010influential citation
• Cerebrovascular protection as a possible mechanism for the protective effects of NXY-059 in preclinical models: an in vitro study.

  2009cites this paper
• Effects of NXY‐059 in experimental stroke: an individual animal meta‐analysis

  2009cites this paper
• Development and efficacy of NXY-059 for the treatment of acute ischemic stroke

  2008cites this paper
• Pharmacological approaches to acute ischaemic stroke: reperfusion certainly, neuroprotection possibly

  2008cites this paper
• The Nitrone Free Radical Scavenger NXY-059 Is Neuroprotective when Administered after Traumatic Brain Injury in the Rat

  2008cites this paper
• Life After Cerovive: A Personal Perspective on Ischemic Neuroprotection in the Post–NXY-059 Era

  2007cites this paper
• Therapeutic strategies for the treatment of stroke.

  2006cites this paper
• NXY-059 for acute ischemic stroke.

  2006cites this paper
• NXY-059: brain or vessel protection.

  2006cites this paper
• Effects of NXY-059 on Cerebral Blood Flow

  2006cites this paper